EAPH-03. FINAL RESULTS OF THE PHASE II, SINGLE ARM TRIAL OF IRINOTECAN AND CISPLATIN IN CHILDREN WITH HIGH-RISK GLIAL TUMORS

We conducted an open label, single arm phase II clinical trial with with irinotecan and cisplatin (I/C) for pediatric patients with glial tumors (EudraCT:2009-010742-59). METHODS: Patients diagnosed with high-risk (HR) gliomas at diagnosis (HGG, ependymomas, DIPG, or HR-LGG) received sixteen weekly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Cruz, Ofelia, Caloretti, Victoria, Suñol, Mariona, de Torres, Carmen, Morales, Andres, Guillen, Antonio, Muchart, Jordi, Rodriguez, Eva, Celis, Veronica, Salvador, Hector, Vinent, Joan, Perez-Jaume, Sara, Mora, Jaume
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012024/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados